These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17699771)

  • 1. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
    Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K
    Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD99 acts as an oncosuppressor in osteosarcoma.
    Manara MC; Bernard G; Lollini PL; Nanni P; Zuntini M; Landuzzi L; Benini S; Lattanzi G; Sciandra M; Serra M; Colombo MP; Bernard A; Picci P; Scotlandi K
    Mol Biol Cell; 2006 Apr; 17(4):1910-21. PubMed ID: 16421247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma.
    Cao Y; Zhou Z; de Crombrugghe B; Nakashima K; Guan H; Duan X; Jia SF; Kleinerman ES
    Cancer Res; 2005 Feb; 65(4):1124-8. PubMed ID: 15734992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
    De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
    J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
    Haydon RC; Luu HH; He TC
    Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
    Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
    Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
    Ferracini R; Di Renzo MF; Scotlandi K; Baldini N; Olivero M; Lollini P; Cremona O; Campanacci M; Comoglio PM
    Oncogene; 1995 Feb; 10(4):739-49. PubMed ID: 7862451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
    Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
    Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity.
    Bender FC; Reymond MA; Bron C; Quest AF
    Cancer Res; 2000 Oct; 60(20):5870-8. PubMed ID: 11059785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 acts as a tumor suppressor by down-regulating epidermal growth factor receptor-mitogen-activated protein kinase signaling pathway in pancreatic carcinoma cell lines.
    Han F; Gu D; Chen Q; Zhu H
    Pancreas; 2009 Oct; 38(7):766-74. PubMed ID: 19893453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
    Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
    J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells.
    Guo Y; Zi X; Koontz Z; Kim A; Xie J; Gorlick R; Holcombe RF; Hoang BH
    J Orthop Res; 2007 Jul; 25(7):964-71. PubMed ID: 17318900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy.
    Rucci N; Recchia I; Angelucci A; Alamanou M; Del Fattore A; Fortunati D; Susa M; Fabbro D; Bologna M; Teti A
    J Pharmacol Exp Ther; 2006 Jul; 318(1):161-72. PubMed ID: 16627750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival.
    Shinomiya N; Gao CF; Xie Q; Gustafson M; Waters DJ; Zhang YW; Vande Woude GF
    Cancer Res; 2004 Nov; 64(21):7962-70. PubMed ID: 15520203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.